#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15468	16S	1529	1529	100.0	16S.l15.c30.ctg.1	1983	885.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1292	1292	C	1019	C	1019	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15468	16S	1529	1529	100.0	16S.l15.c30.ctg.1	1983	885.1	0	HET	.	.	.	C1525T	.	1525	1525	C	1633	1633	C	878	C,T	465,413	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15468	16S	1529	1529	100.0	16S.l15.c30.ctg.1	1983	885.1	0	HET	.	.	.	T1412TGGGGG,TGGGGGG	.	1412	1412	T	1520	1520	T	998	TGGGGG,TGGGGGG	504,427	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25564	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4060	785.0	0	.	n	.	0	T695C	SNP	695	695	T	1294	1294	C	971	C,A,T,G	966,3,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25564	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4060	785.0	0	.	n	.	0	A1638G	SNP	1638	1638	A	2237	2237	G	879	G,T,A	876,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25564	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4060	785.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2570	2570	C	833	C,A	830,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25564	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4060	785.0	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3196	3196	T	915	T,G	912,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25564	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4060	785.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2644	2644	A	814	A	814	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25564	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4060	785.0	0	HET	.	.	.	A20C	.	20	20	A	619	619	A	701	A,C	440,261	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2228	folP	855	855	100.0	folP.l15.c4.ctg.1	2029	136.8	1	SNP	p	R229S	1	.	.	685	687	AGC	1253	1255	AGC	212;211;210	A,G;G;C,T	211,1;211;209,1	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5526	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3805	181.0	1	SNP	p	S91F	1	.	.	271	273	TTC	783	785	TTC	211;211;212	T;T,C,G;C,A	211;209,1,1;211,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5526	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3805	181.0	1	SNP	p	D95G	1	.	.	283	285	GGC	795	797	GGC	224;227;228	G;G,A;C	224;226,1;228	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5526	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3805	181.0	1	SNP	p	G95N	0	.	.	283	285	GGC	795	797	GGC	224;227;228	G;G,A;C	224;226,1;228	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	1964	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1642	148.4	0	.	p	.	0	F184L	NONSYN	550	552	TTC	1090	1092	TTG	192;193;192	T;T;G,T	192;193;191,1	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	1964	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1642	148.4	1	SNP	p	G45D	0	.	.	133	135	GGC	673	675	GGC	250;249;249	G;G;C	250;249;249	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1132	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1418	99.4	0	.	n	.	0	A197.	DEL	197	197	A	798	798	A	223	A	223	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5088	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3342	189.7	1	SNP	p	D86N	0	.	.	256	258	GAC	764	766	GAC	230;230;232	G,T;A,C,T,G;C	229,1;226,2,1,1;232	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5088	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3342	189.7	1	SNP	p	R87I	0	.	.	259	261	CGT	767	769	CGT	233;231;229	C,A;G;T,G	232,1;231;228,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5088	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3342	189.7	1	SNP	p	S87R	1	.	.	259	261	CGT	767	769	CGT	233;231;229	C,A;G;T,G	232,1;231;228,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5088	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3342	189.7	1	SNP	p	R87W	0	.	.	259	261	CGT	767	769	CGT	233;231;229	C,A;G;T,G	232,1;231;228,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5088	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3342	189.7	1	SNP	p	S88P	0	.	.	262	264	TCC	770	772	TCC	228;229;232	T,G;C,A;C	227,1;227,2;232	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4366	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3213	169.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1832	1834	GGC	223;226;226	G,T;G,T;C	221,1;225,1;225	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4140	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2958	174.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1552	1554	GCA	254;256;256	G,C;C;A,C	253,1;256;255,1	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4140	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2958	174.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1555	1557	ATC	255;253;254	A;T;C	255;253;254	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4140	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2958	174.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1567	1569	GTG	261;260;261	G;T;G,T	261;260;260,1	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4140	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2958	174.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1567	1569	GTG	261;260;261	G;T;G,T	261;260;260,1	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4140	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2958	174.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2071	2073	ACC	189;189;189	A;C,G;C	189;188,1;189	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4140	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2958	174.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2125	2127	GCG	185;181;177	G;C,G;G	184;179,1;176	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4140	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2958	174.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2125	2127	GCG	185;181;177	G;C,G;G	184;179,1;176	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4140	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2958	174.6	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2248	2250	AGC	227;228;228	A;G,T;C,T	227;227,1;227,1	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4140	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2958	174.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2257	2259	GGC	231;232;229	G;G,T;C	231;231,1;229	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4140	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2958	174.6	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2275	2277	CCG	246;247;242	C,T,G;C,A;G,A,T	243,1,2;246,1;240,1,1	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5706	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3502	203.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1829	1831	CCG	224;222;224	C;C;G,A	224;222;223,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2542	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2148	147.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	726	726	C	181	C	181	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	328	porB1a	984	156	92.95	porB1a.l15.c4.ctg.1	156	50.5	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	35;38;39	T;T;A	35;38;39	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	328	porB1a	984	156	92.95	porB1a.l15.c4.ctg.1	156	50.5	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	63;63;63	C;A;T	63;63;63	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	328	porB1a	984	156	92.95	porB1a.l15.c4.ctg.1	156	50.5	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	63;63;63	A;G;T	63;63;63	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	328	porB1a	984	156	92.95	porB1a.l15.c4.ctg.1	156	50.5	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	63;63;63	T;A;C	63;63;63	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	328	porB1a	984	100	95.0	porB1a.l15.c4.ctg.2	181	60.1	0	.	p	.	0	M18T	NONSYN	52	54	ATG	133	135	ACG	70;67;64	A;C;G	70;67;64	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	328	porB1a	984	100	95.0	porB1a.l15.c4.ctg.2	181	60.1	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	175	177	CAA	22;16;14	C;A;A	22;16;14	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3018	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1634	222.7	0	.	p	.	0	N38E	NONSYN	112	114	AAT	553	555	GAA	255;255;253	G;A;A	255;255;253	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3018	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1634	222.7	0	.	p	.	0	N134D	NONSYN	400	402	AAT	841	843	GAT	258;263;260	G;A;T	258;263;260	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3018	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1634	222.7	0	.	p	.	0	P175S	NONSYN	523	525	CCA	964	966	TCA	266;266;259	T;C;A	266;266;259	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3018	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1634	222.7	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1093	1095	GTC	247;247;245	G,A;TCCCC,TCCC;C,G	246,1;236,1;244,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3018	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1634	222.7	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1105	1107	TCT	250;253;249	T,G;C,T;T	248,2;252,1;249	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3018	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1634	222.7	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1423	1425	GCA	248;249;247	G;C,A;A	248;248,1;247	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3018	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1634	222.7	1	SNP	p	G120K	1	.	.	358	360	AAG	799	801	AAG	267;267;267	A;A;G	267;267;267	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3018	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1634	222.7	1	SNP	p	A121D	1	.	.	361	363	GAC	802	804	GAC	266;269;271	G,T;A;C	265,1;269;271	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3018	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1634	222.7	1	SNP	p	D121N	0	.	.	361	363	GAC	802	804	GAC	266;269;271	G,T;A;C	265,1;269;271	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9770	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5371	226.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1448	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1395	128.7	1	SNP	p	V57M	1	.	.	169	171	ATG	756	758	ATG	261;259;257	A;T;G	261;259;257	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
